Blood, The Journal of the American Society of Hematology

h5-index:148
h5-median:192

h5-index is the h-index for articles published in the last 5 complete years. It is the largest number h such that h articles published in 2016-2020 have at least h citations each.hide

h5-median for a publication is the median number of citations for the articles that make up its h5-index.hide

#1 Hematology
#18 Health & Medical Sciences

Title / Author	Cited by	Year
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia DA Arber, A Orazi, R Hasserjian, J Thiele, MJ Borowitz, MM Le Beau, ... Blood 127 (20), 2391-2405	4171	2016
The 2016 revision of the World Health Organization classification of lymphoid neoplasms SH Swerdlow, E Campo, SA Pileri, NL Harris, H Stein, R Siebert, ... Blood 127 (20), 2375-2390	3452	2016
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ... Blood 129 (4), 424-447	1697	2017
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes DP Steensma, R Bejar, S Jaiswal, RC Lindsley, MA Sekeres, ... Blood 126 (1), 9-16	834	2015
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib JC Byrd, RR Furman, SE Coutre, JA Burger, KA Blum, M Coleman, ... Blood 125 (16), 2497-2506	622	2015
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with> 30% blasts H Dombret, JF Seymour, A Butrym, A Wierzbowska, D Selleslag, JH Jang, ... Blood 126 (3), 291-299	600	2015
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia EM Stein, CD DiNardo, DA Pollyea, AT Fathi, GJ Roboz, JK Altman, ... Blood 130 (6), 722-731	580	2017
Toxicities of chimeric antigen receptor T cells: recognition and management JN Brudno, JN Kochenderfer Blood 127 (26), 3321-3330	520	2016
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages JF Emile, O Abla, S Fraitag, A Horne, J Haroche, J Donadieu, ... Blood 127 (22), 2672-2681	509	2016
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia SL Maude, DT Teachey, DL Porter, SA Grupp Blood 125 (26), 4017-4023	448	2015
Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial K Fischer, J Bahlo, AM Fink, V Goede, CD Herling, P Cramer, ... Blood 127 (2), 208-215	435	2016
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations RC Lindsley, BG Mar, E Mazzola, PV Grauman, S Shareef, SL Allen, ... Blood 125 (9), 1367-1376	413	2015
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report A Palumbo, S Bringhen, MV Mateos, A Larocca, T Facon, SK Kumar, ... Blood 125 (13), 2068-2074	393	2015
Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group P Sonneveld, H Avet-Loiseau, S Lonial, S Usmani, D Siegel, ... Blood 127 (24), 2955-2962	386	2016
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia SO Ciurea, MJ Zhang, AA Bacigalupo, A Bashey, FR Appelbaum, ... Blood 126 (8), 1033-1040	377	2015
T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma SA Ali, V Shi, I Maric, M Wang, DF Stroncek, JJ Rose, JN Brudno, ... Blood, The Journal of the American Society of Hematology 128 (13), 1688-1700	368	2016
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia CD DiNardo, K Pratz, V Pullarkat, BA Jonas, M Arellano, PS Becker, ... Blood 133 (1), 7-17	355	2019
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia PA Thompson, CS Tam, SM O’Brien, WG Wierda, F Stingo, W Plunkett, ... Blood, The Journal of the American Society of Hematology 127 (3), 303-309	354	2016
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study M Crump, SS Neelapu, U Farooq, E Van Den Neste, J Kuruvilla, J Westin, ... Blood 130 (16), 1800-1808	345	2017
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma J Krejcik, T Casneuf, IS Nijhof, B Verbist, J Bald, T Plesner, K Syed, K Liu, ... Blood 128 (3), 384-394	343	2016

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.